Preparation of the Implant Site With Piezosurgery vs DrillNCT03978923
Observational Study on the Preparation of the Implant Site With Piezosurgery vs Drill: Comparison Between the Two Methods in Terms of Post-operative Pain, Surgical Times and Operational Advantages
An observational study of Preparation of the Implant Site With Piezosurgery vs Drill, run by University of Trieste at 1 site in Italy.
Trial summary
Purpose: Recent advances showed that ultrasonic implant site osteotomy is related with a decreased trauma and a better post operative healing of the surgical site if compared to the traditional drilling techniques. Read more about this study
- Who is it for?
- Ages 45 to 70 yearsHealthy volunteers can take part
- Conditions the study is for
- Preparation of the Implant Site With Piezosurgery vs Drill
- What is being tested?
- preparation of the implant site with Piezosurgery vs drill
- Type of treatment
- Medical device
- How many people
- 75 participants
- Where
- 1 siteItaly
- Study dates
- 1 Jan 2013to 31 Dec 2017
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 to 70 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: . Seventy-five patients were enrolled in the study, 44 women and 31 men, aged between 45 and 70
Who may be able to join
- edentulous or partly edentulous with a bilateral loss of teeth in the maxillary or mandible
- bone type D2 or D3, following Misch classification
Who cannot join
- general contraindications to implant surgery
- severe coagulation disorders
- immunosuppressed or immunocompromised patients
- patients receiving chemotherapy for less than 1 year
- patients on therapy or having taken amino-bisphosphonates intravenously
- patients irradiated to the head or neck
Show all 11Show fewer
- patients with uncontrolled diabetes
- pregnant and lactating patients
- patients with poor oral hygiene and motivation
- patients needing maxillary sinus lift concomitant with implant insertion
- post-extraction sites with acute or purulent infections.
Trial locations and contacts
1 site in 1 country.
Italy1 site
Department of Medical Sciences, University of Trieste
Trieste, Italy, Trieste, 34127
About this study
Purpose: Recent advances showed that ultrasonic implant site osteotomy is related with a decreased trauma and a better post operative healing of the surgical site if compared to the traditional drilling techniques. The micrometric bone cutting control and the operative advantages related to the piezoelectric approach is also characterized by a learning curve for the clinician in surgical practice and an increased operative duration of the procedure. The aim of this investigation was to compare the operative time, the post operative pain and the patients frequency of intake of painkillers in the healing period.
Methods: A total of 75 patients were treated at the Unit of Oral Surgery (Department of Medical Sciences, Surgery and Health, University of Trieste, Italy) in a split mouth model: 75 drill-inserted implants (G1) and 75 piezoelectric device- inserted implants (G2). The Visual Analogue Scale (VAS) was performed to evaluate the post-operative pain at 15 days from the surgery. The operative time and frequency of intake of painkillers was measured.
Read the detailed description
Materials and Methods The study was conducted after the approval of the local ethical Comettee (n. 88-10.05.2018) University of Trieste.
The following study took into account adult patients undergoing implant therapy with insertion of two contralateral conical implants with a diameter between 3.8 and 4.5 mm with a maximum torque of 35 Ncm. One site was prepared with Ultrasonic device (Esacrom, Imola, Italy) while the contralateral was prepared with micromotor and dedicated drills. All patients were treated at the Unit of Oral Surgery (Department of Medical Sciences, Surgery and Health, University of Trieste, Italy). Seventy-five patients were enrolled in the study, 44 women and 31 men, aged between 45 and 70, who underwent implant therapy in the period between January 2013 and December 2017. The inclusion criteria were: edentulous or partly edentulous with a bilateral loss of teeth in the maxillary or mandible and bone type D2 or D3, following Misch classification16.
The exclusion criteria included: general contraindications to implant surgery, severe coagulation disorders, leukocyte or metabolic diseases, immunosuppressed or immunocompromised patients, patients receiving chemotherapy for less than 1 year, patients on therapy or having taken amino- bisphosphonates intravenously, patients irradiated to the head or neck, patients with uncontrolled diabetes, pregnant and lactating patients, patients with poor oral hygiene and motivation, patients needing maxillary sinus lift concomitant with implant insertion, post-extraction sites with acute or purulent infections.
The final sample of the implants inserted was 150 (75 per technique) then identifying two dependent groups: the drill-inserted implants (G1) and the ultrasonic device- inserted implants (G2). Each patient subscribed an informed written consent and underwent a pre-operative oral hygiene session. Two grams of Amoxicillin were administered to each patient in the preoperative phase. Before surgery, each patient made a rinse with a 0.2% chlorhexidine mouthwash for one minute. The surgery was always performed by the same operator (M.M.) to reduce the bias of the study. Loco-regional anesthesia was performed with Mepivacaine hydrochloride with 1:100000 adrenaline.
For the preparation of implant sites using traditional methods, the drills were used following manufacturer's protocol by the implant system in use (WINSIX®- BioSAF IN s.r.l, Trezzano Rosa, Trezzano Rosa, Milano - Italy).
For the preparation of sites was used ultrasonic device, (Surgysonic II, Esacrom S.r.l., Imola, Italy). For the final preparation and insertion of implants, 5-6 ultrasound inserts were used in sequence as follows: tip-shape 1st insert (ES012X) and 2nd insert (ES052XG), crown-shape 3rd insert (ES040), 4th insert (ES041), 5 ° insert (ES043) and 6th insert (ES044).
The implant insertion was performed with a maximum torque of 35 Ncm. Finally, the cap screws were positioned, and the flaps were sutured in Vycril® 3.0.
Each patient was prescribed a 0.2% chlorhexidine mouthwash to be used twice a day for two weeks and paracetamol 1000 mg (maximum 3 tablets a day) as a pain-relieving therapy.
Each patient included in the study was therefore in possession of two questionnaires, one per technique, for the evaluation of the treatment. In the questionnaire the patient was asked to trace an "X" representing the level of pain experienced. The questionnaire recorded the individual symptoms experienced during the surgery, after 8 hours, from the 1st to the 7th day and finally any persistence
of the symptoms on the 15th day after surgery. In the same questionnaire was also asked to indicate the possible intake of painkillers and the related dose, after surgery and in the following six days; moreover, after the fifteenth day, the patient was asked if he have repeated the experience of the implant surgery. Then, for each patient, a postoperative check was scheduled: after one week all the patients were recalled for a post-operative control and the removal of the sutures.
For the subjective analysis of the effects of the two methods, it was decided to use the Visual Analogue Scale (VAS). This linear scale is the visual representation of the amplitude of pain that the patient perceives. It is a horizontal line 100 mm long, in which one end indicates the absence of pain, while the other represents the worst pain imaginable.
During the surgical procedure the preparation times of the implant site were measured from the preparation of the flap up to the insertion of the implant.
Immediately after the end of the surgical procedure, a questionnaire on the operative difficulty was compiled by the operator. In particular, the two techniques were compared considering two factors: the easiness in obtaining a correct axis of implants insertion and the quality of visibility. Furthermore, a cumulative judgement has been done for the whole procedure, as "simple", "of medium difficulty", "difficult".
Statistical Analysis SPSS software (SPSS Inc. Chicago, IL) was used for statistical analysis. A value of p <0.05 was used in rejecting the null hypothesis.
In addition, continuous data were analyzed using non-parametric tests given the asymmetric distribution of some data sets.
Friedman test was used to evaluate the significance of VAS differences within groups over time. Wilcoxon test was used to evaluate the significance of VAS differences within groups and between groups at each time point.
A Cochrane test was used to assess the significance of differences in the frequency of intake of painkillers within groups over time. Subsequently, a McNemar test was used for post-hoc analysis and to assess the significance of differences in the frequency of intake of painkillers between groups each time point.
After having calculated the mean operative times for G1 and G2 Mann-Whitney test was used to compare the differences in surgical times between D2 and D3 bone type within each group while Wilcoxon test was used to intercept the differences between groups in bone type D2 and D3, respectively.
The same McNemar test was used to test the differences in the operator questionnaire answers between groups.
- Being tested
- preparation of the implant site with Piezosurgery vs drill
- Keywords
- ultrasonic surgery, piezosurgery, implant bed preparation, microcracks, pain, crestal bone resorption
- Medical subject headings
- Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
preparation of the implant site with Piezosurgery vs drillDevice
The surgery was always performed by the same operator (M.M.) to reduce the bias of the study. Loco-regional anesthesia was performed with Mepivacaine hydrochloride with 1:100000 adrenaline.
For the preparation of implant sites using traditional methods, the drills were used following manufacturer's protocol by the implant system in use (WINSIX®- BioSAF IN s.r.l, Trezzano Rosa, Trezzano Rosa, Milano - Italy).
For the preparation of sites was used ultrasonic device, (Surgysonic II, Esacrom S.r.l., Imola, Italy). For the final preparation and insertion of implants, 5-6 ultrasound inserts were used in sequence as follows: tip-shape 1st insert (ES012X) and 2nd insert (ES052XG), crown-shape 3rd insert (ES040), 4th insert (ES041), 5 ° insert (ES043) and 6th insert (ES044).
The implant insertion was performed with a maximum torque of 35 Ncm. Finally, the cap screws were positioned, and the flaps were sutured in Vycril® 3.0.
| Study group | Role | What they receive |
|---|---|---|
| the drill-inserted implants (G1) | Not described Receives: Device: preparation of the implant site with Piezosurgery vs drill | |
| the ultrasonic device- inserted implants (G2) | Not described Receives: Device: preparation of the implant site with Piezosurgery vs drill |
What is being measured
The primary outcome is the main question the study is designed to answer.
level of pain experienced
Measured: 1.1.2013-31.12.2017
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Jun 2019
- Study start1 Jan 2013
- Primary completion31 Dec 2017
- Study completion31 Dec 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Preparation of the Implant Site With Piezosurgery vs DrillStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case crossover
- Time perspective
- Prospective
- Enrolment
- 75 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Trieste
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Bevilacqua Lorenzo, University of Trieste
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03978923
- Sponsor's protocol ID
- UTrieste1
- Status last verified
- Jun 2019
- First submitted
- 3 Jun 2019
- Last updated
- 7 Jun 2019
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Maglione M, Bevilacqua L, Dotto F, Costantinides F, Lorusso F, Scarano A. Observational Study on the Preparation of the Implant Site with Piezosurgery vs. Drill: Comparison between the Two Methods in terms of Postoperative Pain, Surgical Times, and Operational Advantages. Biomed Res Int. 2019 Sep 29;2019:8483658. doi: 10.1155/2019/8483658. eCollection 2019.
PubMed 31662998
Study at a glance
From the registry record, last updated by the sponsor on 7 Jun 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Observational Study on the Preparation of the Implant Site With Piezosurgery vs Drill: Comparison Between the Two Methods in Terms of Post-operative Pain, Surgical Times and Operational Advantages
- ClinicalTrials.gov ID
- NCT03978923
- Acronym / sponsor ID
- UTrieste1
- Keywords
- ultrasonic surgery, piezosurgery, implant bed preparation, microcracks, pain, crestal bone resorption
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 75 participants (actual)
- Lead sponsor
- University of TriesteUniversity, hospital or other
- Study start
- 1 Jan 2013 (actual)
- Primary completion
- 31 Dec 2017 (actual)
- Study completion
- 31 Dec 2017 (actual)
- First posted
- 7 Jun 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Purpose: Recent advances showed that ultrasonic implant site osteotomy is related with a decreased trauma and a better post operative healing of the surgical site if compared to the traditional drilling techniques. The micrometric bone cutting control and the operative advantages related to the piezoelectric approach is also characterized by a learning curve for the clinician in surgical practice and an increased operative duration of the procedure. The aim of this investigation was to compare the operative time, the post operative pain and the patients frequency of intake of painkillers in the healing period.
Methods: A total of 75 patients were treated at the Unit of Oral Surgery (Department of Medical Sciences, Surgery and Health, University of Trieste, Italy) in a split mouth model: 75 drill-inserted implants (G1) and 75 piezoelectric device- inserted implants (G2). The Visual Analogue Scale (VAS) was performed to evaluate the post-operative pain at 15 days from the surgery. The operative time and frequency of intake of painkillers was measured.
Detailed description
Materials and Methods The study was conducted after the approval of the local ethical Comettee (n. 88-10.05.2018) University of Trieste.
The following study took into account adult patients undergoing implant therapy with insertion of two contralateral conical implants with a diameter between 3.8 and 4.5 mm with a maximum torque of 35 Ncm. One site was prepared with Ultrasonic device (Esacrom, Imola, Italy) while the contralateral was prepared with micromotor and dedicated drills. All patients were treated at the Unit of Oral Surgery (Department of Medical Sciences, Surgery and Health, University of Trieste, Italy). Seventy-five patients were enrolled in the study, 44 women and 31 men, aged between 45 and 70, who underwent implant therapy in the period between January 2013 and December 2017. The inclusion criteria were: edentulous or partly edentulous with a bilateral loss of teeth in the maxillary or mandible and bone type D2 or D3, following Misch classification16.
The exclusion criteria included: general contraindications to implant surgery, severe coagulation disorders, leukocyte or metabolic diseases, immunosuppressed or immunocompromised patients, patients receiving chemotherapy for less than 1 year, patients on therapy or having taken amino- bisphosphonates intravenously, patients irradiated to the head or neck, patients with uncontrolled diabetes, pregnant and lactating patients, patients with poor oral hygiene and motivation, patients needing maxillary sinus lift concomitant with implant insertion, post-extraction sites with acute or purulent infections.
The final sample of the implants inserted was 150 (75 per technique) then identifying two dependent groups: the drill-inserted implants (G1) and the ultrasonic device- inserted implants (G2). Each patient subscribed an informed written consent and underwent a pre-operative oral hygiene session. Two grams of Amoxicillin were administered to each patient in the preoperative phase. Before surgery, each patient made a rinse with a 0.2% chlorhexidine mouthwash for one minute. The surgery was always performed by the same operator (M.M.) to reduce the bias of the study. Loco-regional anesthesia was performed with Mepivacaine hydrochloride with 1:100000 adrenaline.
For the preparation of implant sites using traditional methods, the drills were used following manufacturer's protocol by the implant system in use (WINSIX®- BioSAF IN s.r.l, Trezzano Rosa, Trezzano Rosa, Milano - Italy).
For the preparation of sites was used ultrasonic device, (Surgysonic II, Esacrom S.r.l., Imola, Italy). For the final preparation and insertion of implants, 5-6 ultrasound inserts were used in sequence as follows: tip-shape 1st insert (ES012X) and 2nd insert (ES052XG), crown-shape 3rd insert (ES040), 4th insert (ES041), 5 ° insert (ES043) and 6th insert (ES044).
The implant insertion was performed with a maximum torque of 35 Ncm. Finally, the cap screws were positioned, and the flaps were sutured in Vycril® 3.0.
Each patient was prescribed a 0.2% chlorhexidine mouthwash to be used twice a day for two weeks and paracetamol 1000 mg (maximum 3 tablets a day) as a pain-relieving therapy.
Each patient included in the study was therefore in possession of two questionnaires, one per technique, for the evaluation of the treatment. In the questionnaire the patient was asked to trace an "X" representing the level of pain experienced. The questionnaire recorded the individual symptoms experienced during the surgery, after 8 hours, from the 1st to the 7th day and finally any persistence
of the symptoms on the 15th day after surgery. In the same questionnaire was also asked to indicate the possible intake of painkillers and the related dose, after surgery and in the following six days; moreover, after the fifteenth day, the patient was asked if he have repeated the experience of the implant surgery. Then, for each patient, a postoperative check was scheduled: after one week all the patients were recalled for a post-operative control and the removal of the sutures.
For the subjective analysis of the effects of the two methods, it was decided to use the Visual Analogue Scale (VAS). This linear scale is the visual representation of the amplitude of pain that the patient perceives. It is a horizontal line 100 mm long, in which one end indicates the absence of pain, while the other represents the worst pain imaginable.
During the surgical procedure the preparation times of the implant site were measured from the preparation of the flap up to the insertion of the implant.
Immediately after the end of the surgical procedure, a questionnaire on the operative difficulty was compiled by the operator. In particular, the two techniques were compared considering two factors: the easiness in obtaining a correct axis of implants insertion and the quality of visibility. Furthermore, a cumulative judgement has been done for the whole procedure, as "simple", "of medium difficulty", "difficult".
Statistical Analysis SPSS software (SPSS Inc. Chicago, IL) was used for statistical analysis. A value of p <0.05 was used in rejecting the null hypothesis.
In addition, continuous data were analyzed using non-parametric tests given the asymmetric distribution of some data sets.
Friedman test was used to evaluate the significance of VAS differences within groups over time. Wilcoxon test was used to evaluate the significance of VAS differences within groups and between groups at each time point.
A Cochrane test was used to assess the significance of differences in the frequency of intake of painkillers within groups over time. Subsequently, a McNemar test was used for post-hoc analysis and to assess the significance of differences in the frequency of intake of painkillers between groups each time point.
After having calculated the mean operative times for G1 and G2 Mann-Whitney test was used to compare the differences in surgical times between D2 and D3 bone type within each group while Wilcoxon test was used to intercept the differences between groups in bone type D2 and D3, respectively.
The same McNemar test was used to test the differences in the operator questionnaire answers between groups.
Study design
- Observational model
- Case crossover
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| the drill-inserted implants (G1) | – | Device: preparation of the implant site with Piezosurgery vs drill |
| the ultrasonic device- inserted implants (G2) | – | Device: preparation of the implant site with Piezosurgery vs drill |
Who may qualify
- Ages
- 45 to 70 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- . Seventy-five patients were enrolled in the study, 44 women and 31 men, aged between 45 and 70
Key inclusion criteria (2 listed)
- edentulous or partly edentulous with a bilateral loss of teeth in the maxillary or mandible
- bone type D2 or D3, following Misch classification
Key exclusion criteria (11 listed)
- general contraindications to implant surgery
- severe coagulation disorders
- immunosuppressed or immunocompromised patients
- patients receiving chemotherapy for less than 1 year
- patients on therapy or having taken amino-bisphosphonates intravenously
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| preparation of the implant site with Piezosurgery vs drillThe surgery was always performed by the same operator (M.M.) to reduce the bias of the study. Loco-regional anesthesia was performed with Mepivacaine hydrochloride with 1:100000 adrenaline. For the preparation of implant sites using traditional methods, the drills were used following manufacturer's protocol by the implant system in use (WINSIX®- BioSAF IN s.r.l, Trezzano Rosa, Trezzano Rosa, Milano - Italy). For the preparation of sites was used ultrasonic device, (Surgysonic II, Esacrom S.r.l., Imola, Italy). For the final preparation and insertion of implants, 5-6 ultrasound inserts were used in sequence as follows: tip-shape 1st insert (ES012X) and 2nd insert (ES052XG), crown-shape 3rd insert (ES040), 4th insert (ES041), 5 ° insert (ES043) and 6th insert (ES044). The implant insertion was performed with a maximum torque of 35 Ncm. Finally, the cap screws were positioned, and the flaps were sutured in Vycril® 3.0. | Device | the drill-inserted implants (G1), the ultrasonic device- inserted implants (G2) |
Primary outcome
level of pain experienced
Time frame: 1.1.2013-31.12.2017
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Jun 2019.
- Derived from this study: PubMed 31662998Maglione M, Bevilacqua L, Dotto F, Costantinides F, Lorusso F, Scarano A. Observational Study on the Preparation of the Implant Site with Piezosurgery vs. Drill: Comparison between the Two Methods in terms of Postoperative Pain, Surgical Times, and Operational Advantages. Biomed Res Int. 2019 Sep 29;2019:8483658. doi: 10.1155/2019/8483658. eCollection 2019.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Preparation of the Implant Site With Piezosurgery vs Drill, run by University of Trieste at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Jun 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
level of pain experienced (time frame: 1.1.2013-31.12.2017). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03978923, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jun 2019.